Nomura Asset Management Co. Ltd. boosted its position in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 95.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,500 shares of the company’s stock after purchasing an additional 1,220 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Pediatrix Medical Group were worth $33,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the company. Pacer Advisors Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth $35,492,000. American Century Companies Inc. lifted its holdings in Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock worth $22,820,000 after buying an additional 1,500,485 shares during the period. Boston Partners grew its position in shares of Pediatrix Medical Group by 25.2% in the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after buying an additional 393,600 shares during the last quarter. Weiss Asset Management LP increased its stake in shares of Pediatrix Medical Group by 50.5% in the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock valued at $10,580,000 after buying an additional 306,143 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $3,066,000. 97.71% of the stock is currently owned by institutional investors.
Pediatrix Medical Group Trading Down 4.8 %
NYSE:MD opened at $13.46 on Friday. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $1.16 billion, a price-to-earnings ratio of -11.22, a PEG ratio of 1.74 and a beta of 1.49. The firm has a fifty day simple moving average of $14.42 and a two-hundred day simple moving average of $13.77.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Macquarie assumed coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 target price for the company. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $17.08.
View Our Latest Analysis on Pediatrix Medical Group
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Stories
- Five stocks we like better than Pediatrix Medical Group
- What Are Earnings Reports?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- 3 Best Fintech Stocks for a Portfolio Boost
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Comparing and Trading High PE Ratio Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.